The content on this site is intended for healthcare professionals only
Pharmacovigilance is essential for ensuring medication safety, and the Namibia Medicines Regulatory Council (NMRC) leads these efforts.
Appointed by the Minister of Health, the NMRC is composed of 12 members and focusses on various aspects of drug safety, including clinical evaluations and vaccine-related adverse events.
Reporting adverse drug reactions is crucial, and specific guidelines are in place for both healthcare professionals and manufacturers to ensure comprehensive monitoring and appropriate responses to safety concerns.
Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG
Enhancing medicine safety monitoring in Zambia
The evolution of pharmacovigilance: Lessons from thalidomide
Advances in pharmacovigilance in Nigeria
McVie-Veronesi awards: 1st Prize - Insights into journeys of cancer patients in India - Access, affordability and barriers
How to approach a breast lump and nipple discharge
Axillary management in breast
Breast cancer staging and biological subtypes clinical application
Bethesda and Beyond – Improving results of FNAC in thyroid nodules
